Posted July 25, 2016
With immense of optimism and confidence, we have agreed to perform a multi-national clinical evaluation for the assessment of our first product, the mfloDx® MDR-TB test. The product will be validated in at least seven WHO sponsored Supernational Reference Laboratories in Europe and Asia. The clinical evaluation is scheduled to start in Jan. 2018.
Posted October 5, 2016
EMPE is excited to announce that we have established clinical consortium with premier TBnet for the clinical evaluation of their products.